porcin
epidem
diarrhea
viru
pedv
alphacoronaviru
famili
coronavirida
singlestrand
positivesens
rna
viru
caus
porcin
epidem
diarrhea
ped
pig
pedv
infect
pig
age
group
result
enter
diseas
high
morbid
high
mortal
rate
observ
neonat
piglet
howev
mortal
usual
low
older
anim
ped
character
vomit
wateri
diarrhea
dehydr
usual
follow
death
suckl
piglet
introduct
usa
pedv
caus
death
million
piglet
result
signific
econom
loss
us
swine
industri
sinc
signific
invest
effort
develop
pedv
vaccin
made
vaccin
receiv
condit
licens
usda
efficaci
vaccin
protect
newborn
piglet
howev
still
unknown
piglet
born
agammaglobulinem
due
imperm
natur
epitheliocori
swine
placenta
immun
system
immatur
make
highli
suscept
pedv
first
week
life
therefor
passiv
transfer
antibodi
colostrum
milk
critic
protect
neonat
piglet
pedv
previou
studi
transmiss
gastroenteritit
viru
tgev
coronaviru
close
relat
pedv
shown
high
correl
milk
antibodi
level
protect
piglet
henc
requir
effect
pedv
vaccin
abil
induc
high
level
antibodi
colostrum
milk
subsequ
transfer
piglet
born
immun
sow
although
sever
attenu
kill
subunit
pedv
vaccin
develop
fail
induc
suffici
level
lactogen
immun
protect
newborn
piglet
thu
critic
develop
improv
altern
current
avail
pedv
vaccin
recent
demonstr
recombin
orf
viru
orfv
express
fulllength
spike
protein
pedv
orfvpedv
capabl
elicit
protect
immun
respons
immun
pig
threeweekold
piglet
immun
intramuscularli
im
orfvpedv
recombin
viru
protect
clinic
sign
ped
oral
challeng
pedv
show
reduc
viru
shed
fece
present
studi
investig
immunogen
orfvpedv
recombin
viru
pregnant
gilt
abil
induc
passiv
immun
protect
piglet
born
immun
anim
recombin
orfvpedv
previous
gener
character
laboratori
propag
titrat
primari
ovin
fetal
turbin
cell
oftu
provid
dl
rock
univers
illinoi
pedv
strain
obtain
nation
veterinari
servic
laboratori
nvsl
propag
cell
presenc
tpcktreat
trypsin
per
ml
sigma
aldrich
st
loui
mo
six
primipar
gilt
randomli
assign
three
experiment
group
follow
group
control
mem
n
group
orfvpedvsimmun
n
group
orfvpedvsimmunizedl
pedvexpos
n
tabl
anim
immun
intramuscularli
im
ml
recombin
orfvpedv
contain
tissu
cultur
infecti
dose
ml
mem
anim
receiv
first
immun
day
two
booster
immun
day
postimmun
pi
second
booster
administ
two
week
prior
anticip
parturit
date
addit
immun
regimen
orfvpedv
describ
gilt
expos
live
pedv
oral
ml
day
pi
anim
shamimmun
ml
mem
describ
anim
hous
anim
room
two
week
prior
farrow
gilt
transfer
individu
farrow
crate
two
crate
per
room
gilt
receiv
mg
day
pi
im
inject
induc
parturit
anim
farrow
day
pi
anim
farrow
day
pi
twelv
piglet
sow
randomli
select
kept
mother
n
per
group
day
allow
suckl
colostrum
milk
ad
libitum
excess
piglet
euthan
keep
sow
equal
number
piglet
n
piglet
challeng
oral
day
postbirth
viru
suspens
contain
pedv
strain
mlpiglet
anim
monitor
daili
clinic
sign
mortal
experi
termin
day
pi
day
postchalleng
pc
clinic
score
evalu
base
four
criteria
modifi
score
method
describ
lohs
collabor
follow
wellb
normal
slightli
depress
depress
letharg
b
defec
normal
fece
semisolid
pasti
wateri
fece
c
vomit
ye
bodi
condit
normal
thin
emaci
mean
daili
group
score
mortal
rate
calcul
compar
differ
group
piglet
show
sever
dehydr
emaci
euthan
base
independ
evalu
sdsu
veterinarian
serum
collect
sow
day
pi
addit
colostrum
milk
collect
sow
day
day
farrow
postfarrow
serum
rectal
swab
collect
piglet
day
precolostrum
prechalleng
postbirth
anim
studi
conduct
sdsu
anim
resourc
wing
arw
follow
guidelin
protocol
approv
sdsu
institut
anim
care
use
committe
iacuc
approv
indirect
elisa
use
truncat
protein
aa
use
assess
igg
iga
antibodi
respons
anim
immun
recombin
orfvpedv
viru
describ
previous
neutral
antibodi
respons
elicit
immun
recombin
orfvpedv
assess
fluoresc
focu
neutral
assay
ffn
describ
previous
pedv
sspecif
igg
iga
antibodi
respons
assess
colostrum
milk
fmia
optim
assay
condit
amount
antigen
colostrummilk
secondari
antibodi
dilut
determin
checkerboard
titrat
viru
shed
assess
rectal
swab
rtqpcr
viral
rna
extract
rectal
swab
use
zymo
viral
rna
extract
kit
zymo
research
ca
usa
accord
manufactur
instruct
primer
probe
target
pedv
nucleocapsid
protein
design
use
primerquest
tool
integr
dna
technolog
inc
usa
rtqpcr
perform
use
probe
lorox
onestep
kit
biolin
usa
follow
manufactur
instruct
genom
copi
number
per
ml
determin
use
rel
standard
curv
method
amount
viral
rna
detect
fece
express
genom
copiesml
gilt
immun
group
develop
pedv
sspecif
igg
iga
respons
fig
b
igg
iga
antibodi
first
detect
day
pi
anim
highest
level
antibodi
detect
day
pi
similarli
igg
iga
antibodi
first
detect
day
pi
level
increas
booster
immun
day
anamnest
antibodi
respons
observ
gilt
expos
live
pedv
day
pi
fig
b
spikespecif
igg
iga
antibodi
detect
serum
control
sow
abil
orfvpedv
induc
neutral
antibodi
na
respons
pedv
assess
use
ffn
assay
na
first
detect
serum
week
first
booster
immun
day
pi
fig
increas
na
level
observ
immun
group
day
pi
fig
gilt
immun
orfvpedv
highest
neutral
antibodi
titer
day
pi
week
second
booster
immun
day
pi
fig
wherea
gilt
immun
orfvpedv
expos
live
pedv
day
pi
highest
antibodi
titer
day
pi
titer
remain
constant
thereaft
end
experi
fig
similar
igg
iga
respons
higher
neutral
antibodi
respons
observ
gilt
compar
anim
neutral
antibodi
pedv
detect
control
gilt
serum
sampl
collect
prefarrowingprechalleng
anim
seroconvert
pedv
present
detect
level
igg
iga
na
week
challeng
piglet
day
postbirth
fig
notabl
strong
correl
na
igg
iga
level
observ
sow
serum
na
vs
igg
r
p
na
vs
iga
r
p
fig
e
result
confirm
previou
find
demonstr
immunogen
orfvpedv
pig
high
level
sspecif
igg
antibodi
detect
day
postfarrow
decreas
thereaft
anim
fig
colostrum
collect
sow
expos
live
pedv
higher
level
igg
compar
day
postfarrow
fig
high
level
sspecif
iga
antibodi
also
detect
colostrum
anim
day
postfarrow
fig
notabl
level
sspecif
iga
antibodi
remain
elev
milk
day
postfarrow
fig
iga
antibodi
level
higher
milk
anim
compar
anim
day
postfarrow
fig
spikespecif
igg
iga
antibodi
detect
colostrummilk
collect
control
sow
fig
b
result
demonstr
abil
orfvpedv
induc
sspecif
igg
iga
antibodi
colostrum
milk
passiv
transfer
antibodi
immun
sow
offspr
assess
elisa
ffn
assay
perform
serum
sampl
collect
piglet
pre
postingest
colostrummilk
sspecif
antibodi
detect
serum
sampl
collect
day
one
prior
ingest
colostrum
fig
notabl
high
level
sspecif
igg
iga
antibodi
detect
serum
piglet
day
postbirth
piglet
born
immun
sow
igg
iga
antibodi
serum
end
experi
day
postbirth
fig
higher
level
igg
antibodi
detect
end
experi
igg
iga
level
higher
piglet
born
sow
compar
piglet
born
sow
spikespecif
igg
iga
detect
serum
piglet
born
control
sow
fig
addit
igg
iga
na
detect
piglet
serum
day
postbirth
high
level
na
detect
piglet
born
orfvpedvsimmun
sow
end
experi
day
pi
fig
neutral
antibodi
detect
piglet
born
control
sow
fig
notabl
signific
correl
na
titer
sow
serum
piglet
serum
observ
r
p
addit
strong
correl
na
igg
iga
antibodi
level
observ
piglet
serum
na
vs
igg
r
p
r
fig
f
togeth
result
demonstr
passiv
transfer
pedvspecif
igg
iga
na
immun
sow
piglet
ingest
colostrum
andor
milk
piglet
born
immun
control
gilt
challeng
oral
virul
pedv
strain
day
postbirth
piglet
monitor
daili
characterist
clinic
sign
ped
mortal
daili
averag
clinic
score
calcul
group
mean
daili
score
present
fig
piglet
born
sow
show
clinic
sign
ped
start
day
pc
last
day
pc
highest
clinic
score
observ
piglet
day
pc
piglet
start
show
clinic
sign
day
pc
moder
diarrhea
observ
continu
day
pc
shown
fig
moresever
clinic
sign
observ
piglet
averag
daili
score
rang
follow
averag
daili
score
rang
averag
daili
score
rang
import
note
piglet
experienc
vomit
diarrhea
none
piglet
group
experienc
vomit
experi
viru
shed
fece
assess
rtqpcr
use
rectal
swab
piglet
significantli
lower
level
viral
rna
fece
p
comparison
piglet
day
pc
fig
howev
signific
differ
viru
shed
fece
observ
three
group
thereaft
daili
mortal
record
piglet
three
group
present
fig
notabl
twelv
piglet
control
die
day
pc
one
piglet
die
day
pc
none
piglet
die
pedv
challeng
interestingli
correl
antibodi
level
piglet
sow
compar
surviv
rate
piglet
moder
strong
correl
na
level
piglet
serum
r
p
iga
igg
antibodi
level
sow
colostrummilk
r
p
r
p
respect
observ
fig
e
f
togeth
result
demonstr
decreas
morbid
mortal
piglet
born
immun
gilt
strong
correl
surviv
antibodi
level
colostrum
milk
present
studi
assess
abil
orfvpedv
induc
passiv
immun
pedv
follow
immun
pregnant
gilt
one
goal
studi
assess
whether
immun
orfvpedv
alon
would
suffici
live
exposur
pedv
would
requir
protect
piglet
born
immun
gilt
underli
experiment
design
pregnant
gilt
either
immun
orfvpedv
orfvpedv
follow
oral
exposur
live
pedv
similar
find
wean
pig
im
immun
gilt
orfvpedv
elicit
pedvspecif
igg
iga
na
expect
booster
provid
live
pedv
exposur
gilt
led
higher
antibodi
respons
serum
colostrum
milk
anim
notabl
passiv
transfer
antibodi
gilt
piglet
observ
pedvspecif
igg
iga
na
detect
serum
piglet
born
immun
gilt
follow
ingest
colostrum
milk
na
antibodi
detect
piglet
serum
show
strong
correl
igg
iga
level
fig
f
although
antibodi
respons
elicit
immun
orfvpedv
alon
lower
comparison
induc
immun
orfvpedv
follow
live
pedv
exposur
level
antibodi
induc
im
immun
orfvpedv
suffici
reduc
neonat
mortal
oral
challeng
pedv
antibodi
present
sow
colostrum
milk
deriv
either
serum
produc
local
mammari
tissu
transfer
pathogenspecif
antibodi
sow
piglet
via
colostrum
milk
critic
protect
pathogen
neonat
phase
piglet
life
context
iga
play
key
role
protect
enter
pathogen
pedv
mainli
stabl
proteolyt
degrad
intestin
remain
gut
lumen
pathogenspecif
iga
effect
inhibitdecreas
viru
infectionrepl
gut
epithelium
result
studi
show
increas
level
iga
milk
immun
anim
parallel
lower
diseas
morbid
mortal
piglet
born
immun
gilt
challeng
pedv
sever
ped
high
mortal
observ
piglet
born
control
gilt
antibodi
respons
detect
piglet
born
gilt
high
level
iga
even
higher
show
lesssever
clinic
sign
reduc
mortal
rate
respect
result
suggest
pedvspecif
iga
detect
piglet
may
contribut
reduc
diseas
sever
mortal
piglet
possibl
antibodi
isotyp
cellmedi
immun
may
play
role
protect
howev
formal
exclud
one
import
observ
studi
reduc
mortal
piglet
versu
control
group
born
gilt
immun
im
orfvpedv
notabl
lower
piglet
mortal
group
parallel
sspecif
igg
iga
na
respons
detect
gilt
passiv
transfer
piglet
togeth
observ
show
parenter
immun
orfvpedv
suffici
induc
protect
level
passiv
immun
pedv
result
corrobor
find
previou
studi
pedv
specificantibodi
detect
serum
colostrummilk
passiv
transfer
piglet
parenter
immun
live
inactiv
andor
subunit
vaccin
candid
although
mechan
underli
phenomenon
remain
unknown
possibl
system
antibodi
could
transfer
sow
serum
colostrum
milk
piglet
altern
immunomodulatori
properti
orfv
vector
use
could
potenti
lead
migrat
antibodysecret
plasma
cell
mammari
gland
result
local
antibodi
product
futur
studi
assess
local
immun
cell
mammari
gland
antibodi
isotyp
intestin
lumen
piglet
born
immun
sow
critic
dissect
precis
mechan
underli
protect
immun
respons
elicit
im
immun
orfvpedv
observ
summari
studi
demonstr
abil
orfvpedv
confer
passiv
immun
pedv
follow
immun
pregnant
gilt
similar
previou
find
wean
pig
im
immun
gilt
orfvpedv
elicit
pedvspecif
igg
iga
na
respons
addit
passiv
transfer
antibodi
gilt
piglet
observ
pedvspecif
igg
iga
na
detect
serum
piglet
born
immun
gilt
follow
ingest
colostrum
milk
